Comparison of Serum Neurofilament Light Chain and Tau Protein Levels in Cases with Autism Spectrum Disorder and Their Healthy Siblings and Healthy Controls

키워드

참고문헌 (81)

1. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Association
2. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, "Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008", MMWR Surveill Summ, 61, pp.1~19 (2012)
3. Baio J, "Prevalence of autism spectrum disorder among children aged 8 years-Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2014. MMWR Surveill Summ 2018;67 : 1-23. Erratum : Vol. 67, No. SS-6", MMWR Morb Mortal Wkly Rep, 67, pp.1280~ (2018)
4. Ashwood P, "The immune response in autism : a new frontier for autism research", J Leukoc Biol, 80, pp.1~15 (2006)
5. Khalil M, "Neurofilaments as biomarkers in neurological disorders", Nat Rev Neurol, 14, pp.577~589 (2018)
6. Giacalone M, "Bioactive nutraceuticals and dietary supplements in neurological and brain disease", pp.17~28 (2015), Academic Press
7. McFadden K, "Evidence for dysregulation of axonal growth and guidance in the etiology of ASD", Front Hum Neurosci, 7, pp.671~ (2013)
8. Kern JK, "Evidence of neurodegeneration in autism spectrum disorder", Transl Neurodegener, 2, pp.17~ (2013)
9. Shukla DK, "White matter compromise of callosal and subcortical fiber tracts in children with autism spectrum disorder : a diffusion tensor imaging study", J Am Acad Child Adolesc Psychiatry, 49, pp.1269~1278 (2010)
10. Shukla DK, "Tract-specific analyses of diffusion tensor imaging show widespread white matter compromise in autism spectrum disorder", J Child Psychol Psychiatry, 52, pp.286~295 (2011)
11. Jeong JW, "Sharp curvature of frontal lobe white matter pathways in children with autism spectrum disorders : tract-based morphometry analysis", AJNR Am J Neuroradiol, 32, pp.1600~1606 (2011)
12. Jou RJ, "Diffusion tensor imaging in autism spectrum disorders : preliminary evidence of abnormal neural connectivity", Aust N Z J Psychiatry, 45, pp.153~162 (2011)
13. Hardan AY, "A proton spectroscopy study of white matter in children with autism", Prog Neuropsychopharmacol Biol Psychiatry, 66, pp.48~53 (2016)
14. Suzuki K, "Microglial activation in young adults with autism spectrum disorder", JAMA Psychiatry, 70, pp.49~58 (2013)
15. Kemper TL, "Neuropathology of infantile autism", J Neuropathol Exp Neurol, 57, pp.645~652 (1998)
16. Lee M, "Nicotinic receptor abnormalities in the cerebellar cortex in autism", Brain, 125(Pt 7), pp.1483~1495 (2002)
17. Bauman ML, "Neuroanatomic observations of the brain in autism : a review and future directions", Int J Dev Neurosci, 23, pp.183~187 (2005)
18. Bailey A, "A clinicopathological study of autism", Brain, 121(Pt 5), pp.889~905 (1998)
19. Palmen SJ, "Neuropathological findings in autism", Brain, 127(Pt 12), pp.2572~2583 (2004)
20. Vargas DL, "Neuroglial activation and neuroinflammation in the brain of patients with autism", Ann Neurol, 57, pp.67~81 (2005)
21. Ritvo ER, "Lower Purkinje cell counts in the cerebella of four autistic subjects : initial findings of the UCLA-NSAC Autopsy Research Report", Am J Psychiatry, 143, pp.862~866 (1986)
22. Schumann CM, "Stereological analysis of amygdala neuron number in autism", J Neurosci, 26, pp.7674~7679 (2006)
23. Courchesne E, "Mapping early brain development in autism", Neuron, 56, pp.399~413 (2007)
24. "The global advisory committee on vaccine safety statement on thiomersal. Weekly epidemiological record on 7 January 2005" (2013)[URL]
25. Lopez-Hurtado E, "A microscopic study of languagerelated cortex in autism", Am J Biochem Biotechnol, 4, pp.130~145 (2008)
26. Evans TA, "The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation", Am J Biochem Biotechnol, 4, pp.61~72 (2008)
27. Sajdel-Sulkowska EM, "Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism", Cerebellum, 8, pp.366~372 (2009)
28. Sajdel-Sulkowska EM, "Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders(ASD)", Cerebellum, 10, pp.43~48 (2011)
29. Sajdel-Sulkowska EM, "Oxidative stress in autism : elevated cerebellar 3-nitrotyrosine levels", Am J Biochem Biotechnol, 4, pp.73~84 (2008)
30. Chauhan A, "Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism", J Neurochem, 117, pp.209~220 (2011)
31. Chauhan A, "Brain region-specific glutathione redox imbalance in autism", Neurochem Res, 37, pp.1681~1689 (2012)
32. Yuan A, "Neurofilaments form a highly stable stationary cytoskeleton after reaching a critical level in axons", J Neurosci, 29, pp.11316~11329 (2009)
33. Yuan A, "Neurofilaments and neurofilament proteins in health and disease", Cold Spring Harb Perspect Biol, 9, pp.a018309~ (2017)
34. Perrot R, "Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration", Mol Neurobiol, 38, pp.27~65 (2008)
35. Garcia ML, "NF-M is an essential target for the myelin-directed"outside-in"signaling cascade that mediates radial axonal growth", J Cell Biol, 163, pp.1011~1020 (2003)
36. Zetterberg H, "Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression", JAMA Neurol, 73, pp.60~67 (2016)
37. Bridel C, "Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology : a systematic review and meta-analysis", JAMA Neurol, 76, pp.1035~1048 (2019)
38. Gaetani L, "Neurofilament light chain as a biomarker in neurological disorders", J Neurol Neurosurg Psychiatry, 90, pp.870~881 (2019)
39. Mielke MM, "Plasma and CSF neurofilament light : relation to longitudinal neuroimaging and cognitive measures", Neurology, 93, pp.e252~e260 (2019)
40. Shahim P, "Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports", Neurology, 88, pp.1788~1794 (2017)
41. Tiedt S, "Serum neurofilament light : a biomarker of neuroaxonal injury after ischemic stroke", Neurology, 91, pp.e1338~e1347 (2018)
42. Uphaus T, "NfL(neurofilament light chain)levels as a predictive marker for long-term outcome after ischemic stroke", Stroke, 50, pp.3077~3084 (2019)
43. Watanabe A, "In vivo phosphorylation sites in fetal and adult rat Tau", J Biol Chem, 268, pp.25712~25717 (1993)
44. de la Monte SM, "Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease", Curr Alzheimer Res, 9, pp.35~66 (2012)
45. Johnson GV, "Tau phosphorylation in neuronal cell function and dysfunction", J Cell Sci, 117(Pt 24), pp.5721~5729 (2004)
46. Shaw GJ, "Serum cleaved Tau protein levels and clinical outcome in adult patients with closed head injury", Ann Emerg Med, 39, pp.254~257 (2002)
47. Nam E, "Serum Tau proteins as potential biomarkers for the assessment of Alzheimer’s disease progression", Int J Mol Sci, 21, pp.5007~ (2020)
48. Jensen AR, "Modern biomarkers for autism spectrum disorder : future directions", Mol Diagn Ther, 26, pp.483~495 (2022)
49. İncekaş Gassaloğlu S, "Validity and reliability analysis of turkish version of Childhood Autism Rating Scale", Turk Psikiyatri Derg, 27, pp.266~274 (2016)
50. Sucuoğlu B, "Sorun davranışlar kontrol listesi Türkçe formunun psikometrik özelliklerinin incelenmesi", Türk Psikol Derg, 18, pp.77~91 (2003)
51. Güvenir T, "Güçler ve Güçlükler Anketi’nin(GGA)Türkçe uyarlamasinin psikometrik özellikleri", Turk J Child Adolesc Ment Health, 15, pp.65~74 (2008)
52. He WC, "Elevated serum neurofilament light chain in children autism spectrum disorder : a case control study", Neurotoxicology, 80, pp.87~92 (2020)
53. Simone M, "Serum neurofilament light chain and glial fibrillary acidic protein as potential diagnostic biomarkers in autism spectrum disorders : a preliminary study", Int J Mol Sci, 24, pp.3057~ (2023)
54. Disanto G, "Serum neurofilament light : a biomarker of neuronal damage in multiple sclerosis", Ann Neurol, 81, pp.857~870 (2017)
55. Verde F, "Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis", J Neurol Neurosurg Psychiatry, 90, pp.157~164 (2019)
56. Johnson EB, "Neurofilament light protein in blood predicts regional atrophy in Huntington disease", Neurology, 90, pp.e717~e723 (2018)
57. Mattsson N, "Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease", JAMA Neurol, 74, pp.557~566 (2017)
58. Lin YS, "Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease", Sci Rep, 8, pp.17368~ (2018)
59. Kuhle J, "Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome", J Neurol Neurosurg Psychiatry, 86, pp.273~279 (2015)
60. Travers BG, "Diffusion tensor imaging in autism spectrum disorder : a review", Autism Res, 5, pp.289~313 (2012)
61. Schneider R, "Temporal dynamics of diffusion metrics in early multiple sclerosis and clinically isolated syndrome : a 2-year follow-up tract-based spatial statistics study", Front Neurol, 10, pp.1165~ (2019)
62. Nitz E, "Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children", Ann Clin Transl Neurol, 8, pp.2013~2024 (2021)
63. Reinert MC, "Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis", Neurol Neuroimmunol Neuroinflamm, 7, pp.e749~ (2020)
64. Evers KS, "Serum neurofilament levels in children with febrile seizures and in controls", Front Neurosci, 14, pp.579958~ (2020)
65. Wang H, "Evaluation of neurofilament light chain as a biomarker of neurodegeneration in X-linked childhood cerebral adrenoleukodystrophy", Cells, 11, pp.913~ (2022)
66. Jin J, "Reference values for plasma neurofilament light chain in healthy Chinese children", Clin Chem Lab Med, 60, pp.e10~e12 (2021)
67. Shahim P, "Cerebrospinal fluid brain injury biomarkers in children : a multicenter study", Pediatr Neurol, 49, pp.31~39 (2013)
68. Kadak MT, "Low Serum level -synuclein and Tau protein in autism spectrum disorder compared to controls", Neuropediatrics, 46, pp.410~415 (2015)
69. Ayaydın H, "High serum levels of serum 100 beta protein, neuron-specific enolase, Tau, active caspase-3, M30 and M65 in children with autism spectrum disorders", Clin Psychopharmacol Neurosci, 18, pp.270~278 (2020)
70. Tai C, "Tau reduction prevents key features of autism in mouse models", Neuron, 106, pp.421~437 (2020)
71. Demirel ÖF, "Total Tau and phosphorylated Tau protein serum levels in patients with schizophrenia compared with controls", Psychiatr Q, 88, pp.921~928 (2017)
72. Frisoni GB, "Alzheimer’s CSF markers in older schizophrenia patients", Int J Geriatr Psychiatry, 26, pp.640~648 (2011)
73. Schönknecht P, "Cerebrospinal fluid Tau protein levels in schizophrenia", Eur Arch Psychiatry Clin Neurosci, 253, pp.100~102 (2003)
74. Andreou D, "Lower plasma total Tau in adolescent psychosis : involvement of the orbitofrontal cortex", J Psychiatr Res, 144, pp.255~261 (2021)
75. Saraçoğlu H, "The study of Tau and phospho Tau protein levels in attention deficit and hyperactivity disorder", Turk J Med Sci, 51, pp.2107~2111 (2021)
76. Isgren A, "Markers of neuroinflammation and neuronal injury in bipolar disorder : relation to prospective clinical outcomes", Brain Behav Immun, 65, pp.195~201 (2017)
77. Jakobsson J, "Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients", Neuropsychopharmacology, 39, pp.2349~2356 (2014)
78. Csabai D, "Reduced synapse and axon numbers in the prefrontal cortex of rats subjected to a chronic stress model for depression", Front Cell Neurosci, 12, pp.24~ (2018)
79. Duarte-Silva E, "Novel insights into the mechanisms underlying depression-associated experimental autoimmune encephalomyelitis", Prog Neuropsychopharmacol Biol Psychiatry, 93, pp.1~10 (2019)
80. Williams MR, "Axonal myelin decrease in the splenium in major depressive disorder", Eur Arch Psychiatry Clin Neurosci, 269, pp.387~395 (2019)
81. Chen MH, "Neurofilament light chain is a novel biomarker for major depression and related executive dysfunction", Int J Neuropsychopharmacol, 25, pp.99~105 (2022)

관련 논문AI추천